Search

everythinglearnresearchcommunity

for

Search:↓

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

p14ARF and p16Ink4a cause hair follicle stem cell aging and dysfunction.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Imuvert can prevent some chemotherapy-induced hair loss.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Dkk4 protein helps control how hair grows and its arrangement.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Afatinib often causes skin problems that need proactive management.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Certain cancer drugs can cause skin issues like rashes and itching.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Applying a specific inhibitor lightens skin and hair color.